Prostate Disease

  • Paul T. Cullen


Up to 50% of men experience at least one episode of prostatitis.1 Prostatitis is actually four different disorders: nonbacterial prostatitis, prostatodynia, acute bacterial prostatitis, and chronic bacterial prostatitis. The constellation of dysuria, perineal pain, urgency, frequency, and nocturia suggests that one of the prostatitis syndromes is present. If there is a urethral discharge, urethritis is the primary consideration. The symptoms of the prostatitis syndromes are similar, with the exception of acute bacterial prostatitis. The findings on digital examination of the prostate gland are inconsistent and nonspecific. Tenderness is present in some patients, but this finding is seen in a similar proportion of patients without prostate disease.


Prostate Cancer Benign Prostatic Hyperplasia Radical Prostatectomy Prostate Gland Watchful Waiting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fowler J. Prostatitis. In: Gillenwater J, Grayback J, Howards S, Duckett J, editors. Adult and pediatric urology. 3rd ed. St. Louis: Mosby, 1996:1715–45.Google Scholar
  2. 2.
    Moul J. Prostatitis. Postgrad Med 1993;94(5):191–4.PubMedGoogle Scholar
  3. 3.
    Neal DE, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 1994; 43:460–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Sanford J, Gilbert D, Sande M. Sanford guide to antimicrobial therapy 1995. Dallas: Antimicrobial Therapy, Inc, 1995.Google Scholar
  5. 5.
    Madsen F, Bruskewitz M. Clinical manifestations of benign prostatic hyperplasia. Urol Clin North Am 1995;22:291–8.PubMedGoogle Scholar
  6. 6.
    McConnell, J, Barry MJ, Bruskewitz RC. Clinical practice guideline no. 8: benign prostatic hyperplasia: diagnosis and treatment. Bethesda: US Department of Health and Human Services, 1994:1–225. AHCPR Publ. No. 94–0582.Google Scholar
  7. 7.
    Hicks R, Cooks J. Managing patients with benign prostatic hyperplasia. Am Fam Physician 1995;52:135–42.PubMedGoogle Scholar
  8. 8.
    Hollander J, Diokno A. Prostatism, benign prostatic hyperplasia. Urol Clin North Am 1996;23:75–86.PubMedCrossRefGoogle Scholar
  9. 9.
    Oesterling J. Benign prostatic hyperplasia, medical and minimally invasive treatment options. N Engl J Med 1995;332: 99–109.PubMedCrossRefGoogle Scholar
  10. 10.
    Hill S, Lawrence S, Lepor H. New use for alpha blockers: benign prostatic hyperplasia. Am Fam Physician 1994;49: 1885–8.PubMedGoogle Scholar
  11. 11.
    Wasson J, Reda D, Bruskewitz R, Elinson J, Keller A, Henderson W. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995;332:75–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Ruckle HC, Klee GG, Oesterling JE. Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc 1994;69:59–68.PubMedCrossRefGoogle Scholar
  13. 13.
    Partin A, Oesterling J. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358–68.PubMedGoogle Scholar
  14. 14.
    Albertsen P, Fryback D, Storer B, Kolon T, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Catalona W. Management of cancer of the prostate. N Engl J Med 1994;331:996–1004.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Paul T. Cullen

There are no affiliations available

Personalised recommendations